136 related articles for article (PubMed ID: 20531222)
1. Augmentation with pregabalin in schizophrenia.
Englisch S; Esser A; Enning F; Hohmann S; Schanz H; Zink M
J Clin Psychopharmacol; 2010 Aug; 30(4):437-40. PubMed ID: 20531222
[TBL] [Abstract][Full Text] [Related]
2. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
Pande AC; Crockatt JG; Feltner DE; Janney CA; Smith WT; Weisler R; Londborg PD; Bielski RJ; Zimbroff DL; Davidson JR; Liu-Dumaw M
Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin in the treatment of schizophrenic anxiety.
Schönfeldt-Lecuona C; Wolf RC; Osterfeld ND; Vasic N; Connemann BJ; Schmid M; Freudenmann RW
Pharmacopsychiatry; 2009 May; 42(3):124-5. PubMed ID: 19452382
[No Abstract] [Full Text] [Related]
6. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
Hadley SJ; Mandel FS; Schweizer E
J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin for the treatment of generalized anxiety disorder.
Wensel TM; Powe KW; Cates ME
Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
[TBL] [Abstract][Full Text] [Related]
8. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pregabalin in alcohol dependence.
Martinotti G; Di Nicola M; Tedeschi D; Mazza M; Janiri L; Bria P
Adv Ther; 2008 Jun; 25(6):608-18. PubMed ID: 18553183
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin in clinical psychiatry and addiction: pros and cons.
Martinotti G
Expert Opin Investig Drugs; 2012 Sep; 21(9):1243-5. PubMed ID: 22725618
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
Goff DC; Keefe R; Citrome L; Davy K; Krystal JH; Large C; Thompson TR; Volavka J; Webster EL
J Clin Psychopharmacol; 2007 Dec; 27(6):582-9. PubMed ID: 18004124
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.
Dobrea C; Buoli M; Arici C; Camuri G; Dell'Osso B; Altamura AC
Expert Opin Drug Saf; 2012 Nov; 11(6):893-9. PubMed ID: 22946673
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.
Glick ID; Bosch J; Casey DE
J Clin Psychopharmacol; 2009 Jun; 29(3):267-71. PubMed ID: 19440081
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
Feltner DE; Crockatt JG; Dubovsky SJ; Cohn CK; Shrivastava RK; Targum SD; Liu-Dumaw M; Carter CM; Pande AC
J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
[TBL] [Abstract][Full Text] [Related]
17. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
[TBL] [Abstract][Full Text] [Related]
18. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial.
Baniasadi M; Hosseini G; Fayyazi Bordbar MR; Rezaei Ardani A; Mostafavi Toroghi H
J Psychiatr Pract; 2014 Nov; 20(6):419-27. PubMed ID: 25406046
[TBL] [Abstract][Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
